Issuu on Google+

Winter 2013 Extracts + Graduates The University of Toledo College of Pharmacy and Pharmaceutical Sciences Magazine for Alumni and Friends I N S I D E Dr. Paul Erhardt is Distinguished From the Dean University Professor life-saving cardiovascular drug, earned him American Critical Care’s Presidential Award for Scientific and Technical Excellence. The story of esmolol’s discovery has been documented in the prestigious American Chemical Society series entitled Chronicles of Drug Discovery. Page 2 2012 Reaccreditation Page 4 Academically Strong and Student-Centered Page 11 A University Rising Page 5 PLACEMENT OF GRADUATES Page 6 Beyond the Borders Page 8 In 2002, Dr. Erhardt was elected President of the International Union of Pure and Applied Chemistry (IUPAC) Division VII Chemistry and Human Health. In 2007, he was awarded the IUPAC Appreciation of Service Award for Outstanding r. Paul Erhardt is a professor of Contributions to the Advancement of Medicinal and Biological Chemistry Worldwide Chemistry. He has displayed and Director of the Center for Drug international leadership in Medicinal Design and Development (CD3). A faculty Chemistry, including presenting exciting member at The University of Toledo since new ideas and predicting future directions 1994, he graduated from Richfield High in the field. Dr. Erhardt was awarded a School in the Minneapolis area. Dr. Erhardt gold medal to recognize his innovation earned a B.A. in Chemistry and a Ph.D. in in medicinal chemistry by the Indian Medicinal Chemistry from University of Society of Chemists and Biologists Minnesota before accepting a postdoctoral at the 2011 International Conference position involving bioanalytical chemistry and on Chemistry for Mankind. Active in drug metabolism at the University of Texas the Society for Biomolecular Sciences at Austin. Dr. Erhardt’s early career involved (SBS) and the American Association of bench-level research as a synthetic medicinal Pharmaceutical Sciences (AAPS), Dr. chemist within the pharmaceutical industry. Erhardt was a founding member of their Dr. Erhardt’s research career embodies highly respective Academic Outreach and Prodrug creative and original work with many notable subcommittees. Locally, his research group contributions. His discovery and chemical participates in the annual Susan G. Komen development of esmolol (Brevibloc®), a D continued on page 3

Extracts and Graduates Winter 2013

Related publications